SCHEMBL10153644

SCHEMBL10153644

COC(=O)C1C(=O)N(OCc2ccccc2)C(=O)c2cc(NCC(=O)c3ccccc3)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
AGTR1 P30556 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
AKR1C3 P42330 1/20 0.41
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
ACHE P22303 3/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
RPS6KA2 Q15349 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10153293 0.87 ACHE (0.45) SMN1; SMN2NPC1RAB9AMAPTACHE
SCHEMBL9959325 0.85 APP (0.42) ALDH1A1HPGDMAPTACHEMAPK1
SCHEMBL10153594 0.85 ACHE (0.45) ALDH1A1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL10153305 0.83 MEN1 (0.46) ALDH1A1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL9959247 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2HPGDMAPTGAA
SCHEMBL9960564 0.81 TRPA1 (0.38) ALDH1A1MAPT
SCHEMBL10153698 0.81 ALDH1A1 (0.39) ALDH1A1MAPTGAACYP2C9
SCHEMBL9958850 0.81 MEN1 (0.43) ALDH1A1HPGDMAPTGAACYP1A2
SCHEMBL10153995 0.79 GRM4 (0.44) SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL10153686 0.77 MEN1 (0.46) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012085003-A1 2-HYDROXYISOQUINOLINE-1,3(2H,4H)-DIONES AND RELATED COMPOUNDS USEFUL AS HIV REPLICATION INHIBITORS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2012-06-28 WO disclosed